Search Browse Earnings

LIPELLA PHARMACEUTICALS INC. — SlamSEC

LIPELLA PHARMACEUTICALS INC.

OTC:LIPO

Pharmaceutical Preparations·PITTSBURGH, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$449,617

+144.2% YoY

FY 2024

Adj. EBITDA

-$4.7M

-1055.2% margin

FY 2024

Net Income

-$4.6M

-1027.3% margin

FY 2024

EPS (Diluted)

-$6.16

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$3.3M

FY 2024

Total Debt

$25,000

FY 2023

Net Cash

$3.3M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.7x

FY 2024

EV / EBITDA

—

Employees

—